sub:provenance {
  beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved." ;
    dce:title "BEL Framework Small Corpus Document" ;
    dc:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" ;
    pav:authoredBy sub:_8 ;
    pav:version "1.6" .
  sub:_7 prov:value """we combined the stimulation with glucose or insulin with the cotreatment with inhibitors
of the insulin receptor tyrosine kinase [hydroxy-2-naphthalenylmethylphosphonic
acid trisacetoxymethyl ester (HNMPA)], PI 3-kinase (wortmannin and LY294002),
and mTOR (rapamycin). As shown in Figs. 1 and 2, HNMPA, wortmannin, LY294002,
and rapamycin inhibited both glucose- and insulin-stimulated insulin biosynthesis
in both human pancreatic islets and RIN β-cells.""" ;
    prov:wasQuotedFrom pubmed:15001544 .
  sub:_8 rdfs:comment "support@belframework.org" ;
    rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:15001544 ;
    prov:wasDerivedFrom beldoc: , sub:_7 .
}